Earlier-line bispecific therapy leverages lower disease refractoriness to drive deeper, more durable responses than typically ...

Therapeutic progress in lung squamous cell carcinoma has lagged, with recent antiangiogenic–checkpoint inhibitor combinations ...

Success in cancer care increasingly includes survivorship outcomes, emphasizing durable function and symptom control for patients cured and those with prolonged metastatic disease. Variable survival ...

I was participating in a Drumming Clinical Study, which I really enjoyed. And I was so disappointed that I was unable to ...

Mesothelin-targeted CAR-NKT cells leveraged three recognition mechanisms, potentially limiting antigen escape and ...

A foundational guide for stage 2 prostate cancer clarifies staging implications, localized-disease management, and trade-offs among surgery, radiation, and quality-of-life outcomes to support informed ...

Broad endorsement for insurance-covered blood-based CRC screening (92%) suggests payer policy could materially influence ...

Patients with HER2-positive breast cancer in the FLAMINGO-01 phase 3 clinical trial are seeing a continued reduction in recurrence rates, Greenwich LifeSciences, Inc. has reported. The preliminary ...

In this segment, Dr. Gregory Vidal explains why it is essential for patients to understand their hormone receptor status and ...

In this segment, Dr. Gregory Vidal discusses how common metastatic breast cancer is and explains how it may develop over time ...

Survivor Casey Liening discusses her metastatic breast cancer journey, reaching NED, and why a stage 4 diagnosis is a beginning, not a death sentence.

For many, a stage 4 breast cancer diagnosis can feels scary, but Casey Liening is rewriting that narrative. After a two-year ...